Question 1

Has Kye Lear received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $3,684 in general payments to Kye Lear across 271 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Kye Lear did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Kye Lear come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie(2 entities)	57	$658
AstraZeneca	29	$432
Pfizer	30	$403
Lilly USA, LLC	28	$310
Boehringer Ingelheim	17	$266
Merck	18	$234
Amarin Pharma, Inc.	10	$138
Biohaven Pharmaceuticals, Inc.	12	$123
Bayer	6	$114
Astellas Pharma US Inc	6	$111
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$109
GSK	7	$107
Esperion Therapeutics, Inc.	6	$106
Genentech USA, Inc.	5	$98
Avanir Pharmaceuticals, Inc.	5	$76
Supernus Pharmaceuticals, Inc.	2	$64
Amgen	4	$57
E.r. Squibb & Sons, L.L.C.	4	$50
Novo Nordisk	3	$40
Eisai Inc.	3	$38
Tactile Systems Technology Inc	2	$33
Kowa Pharmaceuticals America, Inc.	2	$27
Mylan Specialty L.p.	1	$26
Antares Pharma, Inc.	2	$25
Takeda Pharmaceuticals U.S.A., Inc.	2	$15
Johnson & Johnson	1	$12
Alfasigma USA, Inc.	1	$12

Kye Lear

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Lubbock